Global Industry Analysts Inc. (GIA)
announces the release of a comprehensive global report on Bioinformatics
markets. The global Bioinformatics market is forecast to reach US$6.8 billion
by the year 2017. Principal factors driving market growth include significant
development in the field of genomics and its ever-growing application in the
research and development processes; breakthrough technologies in drug discovery
initiatives; and the entry of new market players along with the growth in size
and revenues of existing companies. Going forwards, the penetration of genomics
in drug discovery is expected to increase further, which bodes tremendous
market prospects for bioinformatics.
Research and
Development Extent
Backed by significant developments in
the area of genomics, there is increase in the overall volume of distinct
biological data, which includes protein and gene sequences. This leaves an
arduous task for R&D laboratories of analysis. Data management tools based
on bioinformatics have helped companies in easing this task, thereby enhancing
their productivity by way of identifying new biomarkers for toxicity and drug
efficacy, diagnostic biomarkers as well as new drug targets. Bioinformatics
help utilization of this gene and protein data and construct interactive models
that aid in identifying disease pathways and effects of compounds. The
penetration of genomics in drug discovery is expected to witness further
growth, which bodes tremendous market prospects for bioinformatics. It is
expected that more and more investments would be made by pharmaceutical
companies in research and development initiatives, of which a major chunk would
be towards bioinformatics. Concerns associated with patent expiries of several
blockbuster drugs, shrinking product pipelines, and increasing drug development
costs are driving pharma companies to seek help from biotechnology.
Bioinformatics, being helpful at every stage of R&D processes in
biotechnology and pharmaceutical sectors, offers increasing potential for future
growth.
Market Reports
Related to Applications in Bioinformatics
The market of bioinformatics report
includes market dynamics and trends in order to give a thorough analysis of the
overall competitive scenario in the global bioinformatics market. Thus, market
overview section of the report demonstrates market dynamics and trends such as
the drivers, restraints, and opportunities that influence the current nature
and future status of bioinformatics market globally. Impact factors such as
market attractiveness analysis (by geography), market share analysis by key
players and Porter’s five forces (bargaining power of suppliers, bargaining
power of buyers, threat of substitutes, threat of new entrants and competitive
rivalry) analysis have also been explained in the market overview section of
the report. Further, this report includes average selling price analysis (in
terms of USD) and value chain analysis of bioinformatics market.
Further, the global bioinformatics
market is classified into application namely, preventive medicine, molecular
medicine, gene therapy, drug development and others. The present and future
market sizes (in terms of USD million) of the above mentioned application
segments have been given in the report for the period of 2012- 2020 along with
their compound annual growth rate (CAGR %) for the period 2014 to 2020. The
study further provides recommendations which would be useful for the current
and future market players to sustain and grow in the global bioinformatics
market.
The report further includes market
analysis of regional markets namely, North America, Europe, Asia-Pacific, and
Rest of the World (RoW). A thorough market analysis and forecast for these
regional markets has been provided in this study, in terms of market revenue
(USD million) for the period 2012 to 2020. The report also provides the
compounded annual growth rate (CAGR %) for each regional market for the
forecast period of 2014 to 2020, while market size estimations have been made
considering 2013 as the base year.
Bioinformatics
Companies Concern
Bioinformatics globally is a fairly
concentrated market characterized by few large companies and several small
players. About 55% of the companies are based in the US, while 30% are based in
Europe. Major players profiled in the report include 3rd Millennium Inc., Accelrys
Inc., Affymetrix Inc., Agilent Technologies, Celera Group, Gene Logic, Geneva
Bioinformatics S.A, IBM Life Sciences, ID Business Solutions Ltd., Instem
Scientific Limited (Formerly BioWisdom, Ltd.), Life Technologies Corp., Kinexus
Bioinformatics Corp., Nonlinear Dynamics Ltd., among others.
Bioinformatics Department
BII Noida
